Lung Adenocarcinoma with <i>EGFR</i> Amplification Has Distinct Clinicopathologic and Molecular Features in Never-Smokers
Lynette M. Sholl(Brigham and Women's Hospital), Lucian R. Chirieac(Brigham and Women's Hospital)
Cited by 121
Related Papers
Primary Pulmonary NUT Midline Carcinoma: Clinical, Radiographic, and Pathologic Characterizations
|Journal of Thoracic Oncology|2015|132
Programmed Death Ligand-1 and Tumor Mutation Burden Testing of Patients With Lung Cancer for Selection of Immune Checkpoint Inhibitor Therapies: Guideline From the College of American Pathologists, Association for Molecular Pathology, International Association for the Study of Lung Cancer, Pulmonary Pathology Society, and LUNGevity Foundation
|Archives of Pathology & Laboratory Medicine|2024|35